Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
about
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entryDistinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virusTMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike proteinMiddle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak controlMechanisms of coronavirus cell entry mediated by the viral spike proteinStructures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common ThemeFusion of Enveloped Viruses in Endosomes.Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining stepProteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysisRole of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.Structure, Function, and Evolution of Coronavirus Spike Proteins.Autographa californica multicapsid nucleopolyhedrovirus efficiently infects Sf9 cells and transduces mammalian cells via direct fusion with the plasma membrane at low pHElastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain.The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cellsReceptor-independent infection of murine coronavirus: analysis by spinoculationConformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain.Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses.Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation.Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.Role of proteases in the release of porcine epidemic diarrhea virus from infected cells.Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.Incorporation of spike and membrane glycoproteins into coronavirus virions.Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chlorideSuppression of coronavirus replication by inhibition of the MEK signaling pathway.Host cell proteases: Critical determinants of coronavirus tropism and pathogenesisReady, set, fuse! The coronavirus spike protein and acquisition of fusion competenceSimultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry.Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells.Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathwayAnimal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection.Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein.Protease-mediated entry via the endosome of human coronavirus 229E.Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
P2860
Q24306622-0C5DE209-28ED-4A10-9370-970BAAAC77BBQ24337838-3C5040E8-28CD-450F-819D-4648098BCEC0Q24339582-B3E967DC-7A81-44C0-8229-CD787311CEE8Q26796501-42B7D743-E4D1-46FC-87CD-81A47D6A0884Q27027678-000441F5-1747-49FA-A651-AA4981EE25D6Q27487974-1F461A72-3ADC-42FC-A186-67D2306E8C20Q28073406-8ADD75D4-F4C1-43A5-9F57-E269995D3BB4Q30301030-F859C7F9-0009-438A-8830-FEC4CB52BFCBQ30354466-B302A12F-CC2C-4713-9327-EDD0F73D606CQ30365699-51FFA5E6-D236-4D8E-8D93-6D582BA207D3Q30432156-88EB1686-A034-4062-9874-8DEA7BF6878FQ30436297-03A947F5-891F-4536-9837-43212B548E5CQ30439990-F5F0C005-8FA0-414C-B84A-4844E3D50072Q33516234-88151D59-9D3D-48E5-81F4-4257599CEA83Q33760875-78B35265-59C3-4807-9AA5-9112B3022423Q33826852-10CC1DE5-B754-45BA-A76C-33C091826CCAQ34003783-93C8BA70-C7AC-41E3-B99B-D6186C93657AQ34015988-9DE405C2-CE81-4EC8-9EEF-D525F11C9C21Q34193942-75AE87DB-C292-4105-8352-6A58BE726B4BQ34545634-E615E194-3A1D-4862-B6E8-A1E8C57B47F7Q34647808-B1C86D17-B71F-4C43-99E5-862DDB558E0BQ34717693-5A803D51-D7DB-463B-BA77-247D27C358BEQ34983662-F891B1CD-FB83-4C04-AEE1-9A81DED37488Q35009468-7095C657-EDC0-43F3-B7FE-FE197204EE37Q35076795-69A5D291-F12A-48EF-B0AD-F5BA5A5B2C69Q35140298-2B68F147-B17E-4C4F-9A60-4AE54D7600BDQ35399141-666C12DC-05CD-4AFA-ABFB-85CD164F4C34Q35544383-CF6A4013-2CDD-41D2-BF01-10FBFE10EDD2Q35613695-DB6CAF1E-FC85-4230-9839-882F4CFB1220Q35634933-395ABF6C-4161-4294-857D-0FA3E61911DEQ35735214-830F58DE-AF54-4346-BB90-5698313DDEE6Q35943657-0120AA97-3D47-424D-BFC1-E46A82AA8359Q36086649-58484386-583D-4CB7-BD25-1E32ABD74E88Q36099072-4FE00CB7-16D4-42D0-A84A-09CFD5E16583Q36424025-9359BC7E-4806-4C82-A740-85DE1DD2F496Q36447896-CCA20F48-6BDD-4607-9315-6C07B3E4950DQ36520754-D5D17EDB-5CA1-448C-94EF-A84A4FDD8D5FQ36974675-3BD6B925-0527-4064-A278-E100DFEF4D45Q37033358-1711EDE5-A710-4450-B073-C9E03C9E8071Q37138587-BE379F06-B7BF-4CDC-A806-94B488913106
P2860
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
@ast
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
@en
type
label
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
@ast
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
@en
prefLabel
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
@ast
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
@en
P2093
P2860
P356
P1476
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
@en
P2093
Fumihiro Taguchi
Makoto Ujike
Masato Tashiro
Shutoku Matsuyama
P2860
P304
12543-12547
P356
10.1073/PNAS.0503203102
P407
P577
2005-08-22T00:00:00Z